跳至主要内容
临床试验/NCT01000766
NCT01000766已完成不适用

Identification of New Biomarkers of Drug Induced Liver Injury

University of North Carolina, Chapel Hill1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2009年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
25
试验地点
1

研究概览

简要总结

The purpose of this study is to try to develop new blood tests that may help doctors identify if a drug is hurting a person's liver.

详细描述

Our hypothesis is that there are liver-specific particles, called mRNA, that are identifiable in a person's blood sample during liver injury caused by some drugs. The purpose of this study is to try to develop new blood tests that may help doctors identify if a drug is hurting a person's liver, perhaps early in the process before significant injury or illness have occurred.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ALT > 200 IU/L at presentation to UNC Hospitals
  • Drug induced liver injury considered likely by admitting medical staff

排除标准

  • 未提供

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Identifying Changes in Blood (Potential Biomarkers)... | 临床试验